{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:05:00Z","timestamp":1792631100741,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.exppara.2019.03.009","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T12:44:25Z","timestamp":1553085865000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis"],"prefix":"10.1016","volume":"200","author":[{"given":"Mahbobeh","family":"Montazeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1665-6621","authenticated-orcid":false,"given":"Saeed","family":"Emami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Asgarian-Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheil","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahabeddin","family":"Sarvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5517-1662","authenticated-orcid":false,"given":"Shaban","family":"Gohardehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Daryani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2019.03.009_bib1","series-title":"Medicinal Chemistry and Drug Design","article-title":"Kojic acid derivatives","author":"Aytemir","year":"2012"},{"key":"10.1016\/j.exppara.2019.03.009_bib2","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1016\/j.ejmech.2010.05.069","article-title":"A study of cytotoxicity of novel chlorokojic acid derivatives with their antimicrobial and antiviral activities","volume":"45","author":"Aytemir","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.exppara.2019.03.009_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.vetpar.2011.12.039","article-title":"Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models","volume":"187","author":"Barbosa","year":"2012","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2019.03.009_bib4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.yrtph.2003.09.002","article-title":"Production of toxic metabolites in Aspergillus niger, Aspergillus oryzae, and Trichoderma reesei: justification of mycotoxin testing in food grade enzyme preparations derived from the three fungi","volume":"39","author":"Blumenthal","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.exppara.2019.03.009_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/rtph.2000.1442","article-title":"Evaluation of health aspects of kojic acid in food","volume":"33","author":"Burdock","year":"2001","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.exppara.2019.03.009_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fcimb.2017.00340","article-title":"Enrofloxacin and toltrazuril are able to reduce Toxoplasma gondii growth in human BeWo trophoblastic cells and villous explants from human third trimester pregnancy","volume":"7","author":"Da Silva","year":"2017","journal-title":"Front Cell. Infect. Microbiol."},{"key":"10.1016\/j.exppara.2019.03.009_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-065X.2010.00990.x","article-title":"Invasion and intracellular survival by protozoan parasites","volume":"240","author":"David Sibley","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.exppara.2019.03.009_bib8","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.4049\/jimmunol.160.7.3427","article-title":"Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis","volume":"160","author":"Deckert-Schl\u00fcter","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2019.03.009_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1462-5822.2003.00258.x","article-title":"In the belly of the beast: subversion of macrophage proinflammatory signalling cascades during Toxoplasma gondii infection","volume":"5","author":"Denkers","year":"2003","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.exppara.2019.03.009_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3831\/KPI.2017.20.026","article-title":"Anti-Toxoplasma effects of methanol extracts of Feijoa sellowiana, Quercus castaneifolia, and Allium paradoxum","volume":"20","author":"Ebrahimzadeh","year":"2017","journal-title":"J. Pharmacopuncture"},{"key":"10.1016\/j.exppara.2019.03.009_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.exppara.2015.06.005","article-title":"Could miltefosine be used as a therapy for toxoplasmosis?","volume":"157","author":"Eissa","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2019.03.009_bib12","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s12639-015-0712-y","article-title":"In vivo effect of anti-TNF agent (etanercept) in reactivation of latent toxoplasmosis","volume":"40","author":"El-Sayed","year":"2016","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.exppara.2019.03.009_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bmcl.2006.09.097","article-title":"Kojic acid and its manganese and zinc complexes as potential radioprotective agents","volume":"17","author":"Emami","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.exppara.2019.03.009_bib14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1096\/fj.06-7314com","article-title":"Schistosome egg production is dependent upon the activities of two developmentally regulated tyrosinases","volume":"21","author":"Fitzpatrick","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.exppara.2019.03.009_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exppara.2014.05.005","article-title":"Chitosan and silver nanoparticles: promising anti-toxoplasma agents","volume":"143","author":"Gaafar","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2019.03.009_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2131\/jts.32.143","article-title":"Kojic acid-absence of tumor-initiating activity in rat liver, and of carcinogenic and photo-genotoxic potential in mouse skin","volume":"32","author":"Higa","year":"2007","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.exppara.2019.03.009_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ijpara.2003.12.009","article-title":"Toxoplasma gondii: the model apicomplexan","volume":"34","author":"Kim","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2019.03.009_bib18","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1399-3046.2007.00891.x","article-title":"Breakthrough cerebral toxoplasmosis in a patient receiving atovaquone prophylaxis after a hematopoietic stem cell transplantation","volume":"12","author":"Megged","year":"2008","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.exppara.2019.03.009_bib19","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1586\/eri.12.58","article-title":"Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment","volume":"10","author":"Moncada","year":"2012","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.exppara.2019.03.009_bib20","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1128\/AAC.01323-16","article-title":"Evaluation of propranolol effect on experimental acute and chronic toxoplasmosis using quantitative PCR","volume":"60","author":"Montazeri","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2019.03.009_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2017.00025","article-title":"A systematic review of in vitro and in vivo activities of anti-Toxoplasma drugs and compounds (2006\u20132016)","volume":"8","author":"Montazeri","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.exppara.2019.03.009_bib22","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00436-018-6027-z","article-title":"Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review","volume":"117","author":"Montazeri","year":"2018","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2019.03.009_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2018.02587","article-title":"Drug resistance in Toxoplasma gondii","volume":"9","author":"Montazeri","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.exppara.2019.03.009_bib24","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"Montoya","year":"2004","journal-title":"Toxoplasmosis Lancet"},{"key":"10.1016\/j.exppara.2019.03.009_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-065X.2010.00992.x","article-title":"Immunology of Toxoplasma gondii","volume":"240","author":"Munoz","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.exppara.2019.03.009_bib26","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1128\/AAC.00057-15","article-title":"Reduction of Toxoplasma gondii development due to inhibition of parasite antioxidant enzymes by a dinuclear iron (III) compound","volume":"59","author":"Portes","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2019.03.009_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/CBI20100083","article-title":"Kojic acid, a secondary metabolite from Aspergillus sp., acts as an inducer of macrophage activation","volume":"35","author":"Rodrigues","year":"2011","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.exppara.2019.03.009_bib28","doi-asserted-by":"crossref","first-page":"e91259","DOI":"10.1371\/journal.pone.0091259","article-title":"A novel function for kojic acid, a secondary metabolite from Aspergillus fungi, as antileishmanial agent","volume":"9","author":"Rodrigues","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2019.03.009_bib29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijpara.2006.01.006","article-title":"Proliferation of Toxoplasma gondii in inflammatory macrophages in vivo is associated with diminished oxygen radical production in the host cell","volume":"36","author":"Shrestha","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2019.03.009_bib30","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2019.03.009_bib31","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1021\/ol800058d","article-title":"Modular synthesis of candidate indole-based insulin mimics by Claisen rearrangement","volume":"10","author":"Xiong","year":"2008","journal-title":"Org. Lett."},{"key":"10.1016\/j.exppara.2019.03.009_bib32","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.4049\/jimmunol.160.3.1340","article-title":"Decreased resistance of TNF receptor p55-and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo","volume":"160","author":"Yap","year":"1998","journal-title":"J. Immunol."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489418304144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489418304144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:24:37Z","timestamp":1758003877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489418304144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":32,"alternative-id":["S0014489418304144"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2019.03.009","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2019.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}